Nutritional and pharmacological strategy in children with short bowel syndrome
- PMID: 33392698
- DOI: 10.1007/s00383-020-04781-2
Nutritional and pharmacological strategy in children with short bowel syndrome
Abstract
Short bowel syndrome in neonates is a severe and life-threatening disease after a major loss of small bowel with or without large bowel. Intestinal adaptation, by which the organism tries to restore digestive and absorptive capacities, is entirely dependent on stimulation of the active enterocytes by enteral nutrition. This review summarizes recent knowledge about the pathophysiologic consequences after the loss of different intestinal parts and outlines the options for enteral nutrition and pharmacological therapies to support the adaptation process.
References
-
- Aunsholt et al (2014) Bovine colostrum to children with short bowel syndrome: a randomized, double-blind, crossover pilot study. J Parenter Enter Nutr 38:99–106 - DOI
-
- Berg JK et al (2014) A randomized, double-blind, placebo-controlled, multiple dose, ptallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects. BMC Gstroenterol 14:1–9
-
- Bines J et al (1998) Reducing parenteral requirement in children with short bowel syndrome: impact of amino acid-based complete infant formula. JPGN 26:123–128 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources